Pierre Saintigny

Oncology

210 Ashville Ave # 408
Cary, NC 27518

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 128 publications

Worldwide Innovative Network Consortium: Building a Common Global Cancer Database.

Worldwide Innovative Network Consortium: Building a Common Global Cancer Database.

Journal: JCO global oncology

Published: August 13, 2026

Corrigendum to "Management and survival of patients with cancer of unknown primary discussed by a French national multidisciplinary tumour board: a retrospective analysis" The Lancet Regional Health - Europe, Volume 60, January 2026, 101524.

Corrigendum to "Management and survival of patients with cancer of unknown primary discussed by a French national multidisciplinary tumour board: a retrospective analysis" The Lancet Regional Health - Europe, Volume 60, January 2026, 101524.

Journal: The Lancet regional health. Europe

Published: July 30, 2026

Pattern-Anchored Diagnosis of Oral Epithelial Dysplasia: A Position Paper From COST Action INTERCEPTOR Working Group 2.

Pattern-Anchored Diagnosis of Oral Epithelial Dysplasia: A Position Paper From COST Action INTERCEPTOR Working Group 2.

Journal: Head and neck pathology

Published: July 09, 2026

Integration of radiation therapy with systemic treatments in head and neck cancer: expert opinion and roadmap to consensus.

Integration of radiation therapy with systemic treatments in head and neck cancer: expert opinion and roadmap to consensus.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: March 30, 2026

Multi-class semantic segmentation of oral cancer tissues on whole-slide images: A SuperPixel enhanced deep learning approach.

Multi-class semantic segmentation of oral cancer tissues on whole-slide images: A SuperPixel enhanced deep learning approach.

Journal: Journal of pathology informatics

Published: March 26, 2026

Durvalumab combined with weekly carboplatin/paclitaxel as first-line treatment of patients with recurrent and/or metastatic HNSCC not eligible for cisplatin-based chemotherapies: results of the multicenter prospective study FRAIL-IMMUNE.

Durvalumab combined with weekly carboplatin/paclitaxel as first-line treatment of patients with recurrent and/or metastatic HNSCC not eligible for cisplatin-based chemotherapies: results of the multicenter prospective study FRAIL-IMMUNE.

Journal: ESMO open

Published: January 07, 2026

Integrating transcriptomic data and artificial intelligence to personalize curative treatments for head and neck cancer patients.

Integrating transcriptomic data and artificial intelligence to personalize curative treatments for head and neck cancer patients.

Journal: NPJ precision oncology

Published: October 22, 2025

Molecular and Immune Landscape of Recurrent and/or Distant Metastatic Squamous Cell Carcinoma of the Head and Neck: An EORTC/IMMUCAN Project.

Molecular and Immune Landscape of Recurrent and/or Distant Metastatic Squamous Cell Carcinoma of the Head and Neck: An EORTC/IMMUCAN Project.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: September 11, 2025

Genomic and Immune Landscape of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Progressing on Anti-PD-1 Treatment.

Genomic and Immune Landscape of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Progressing on Anti-PD-1 Treatment.

Journal: Cancer immunology research

Published: August 07, 2025

Management and survival of patients with cancer of unknown primary discussed by a French national multidisciplinary tumour board: a retrospective analysis.

Management and survival of patients with cancer of unknown primary discussed by a French national multidisciplinary tumour board: a retrospective analysis.

Journal: The Lancet regional health. Europe

Published: July 07, 2025

Mapping immune activity in HPV-negative head and neck squamous cell carcinoma: a spatial multiomics analysis.

Mapping immune activity in HPV-negative head and neck squamous cell carcinoma: a spatial multiomics analysis.

Journal: Journal for immunotherapy of cancer

Published: June 11, 2025

Frizzled 7 drives amplification of cancer stem-cell subpopulations and the aggressiveness and poor differentiation of human hepatocellular carcinoma.

Frizzled 7 drives amplification of cancer stem-cell subpopulations and the aggressiveness and poor differentiation of human hepatocellular carcinoma.

Journal: PloS one

Published: May 30, 2025

Showing 1-12 of 128

Last Updated: 09/26/2026